Jan Molenaar: Our study on single-cell analysis of Neuroblastoma tumors
Guillermo Chantada, President of SIOP, shared a LinkedIn post by Jan Molenaar, Principal Investigator at Princess Máxima Center for Pediatric Oncology, adding:
“Seminal contribution by Jan Molenaar lab at Prinses Máxima Center for Pediatric Oncology exciting new concepts for immunotherapy.”
Quoting Jan Molenaar’s post:
“Now available at Cancer-Cell, our study on single-cell analysis of Neuroblastoma tumors which identified the Nectin2-TIGIT axis as a new therapeutic target.
Great work of Judith Wienke, team Molenaar, and collaborators. And of course, this wouldn’t have been possible without Stichting Villa Joep, Stichting Kinderen Kankervrij, and Prinses Máxima Center for Pediatric Oncology.”
Proceed to the article.
Source: Guillermo Chantada/LinkedIn and Jan Molenaar/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023